United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - butylscopolamine bromide (unii: 0gh9jx37c8) (butylscopolamine - unii:2z3e1of81v) -

United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - butylscopolamine bromide (unii: 0gh9jx37c8) (butylscopolamine bromide - unii:0gh9jx37c8) -

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - scopolamine (unii: dl48g20x8x) (scopolamine - unii:dl48g20x8x) - transderm scōp® is indicated in adults for prevention of nausea and vomiting associated with motion sickness.[see clinical studies (14.1)] transderm scōp® is indicated in adults for prevention of nausea and vomiting associated with recovery from anesthesia and/or opiate analgesia and surgery. [see clinical studies (14.2)] transderm scōp® is contraindicated in the following populations: pregnancy category c based on data from one prospective study of transderm scōp® in cesarean delivery, the rate of newborn adverse events in both the transderm scōp® and placebo groups were the same. the rates were 10.5% (12 events in 114 newborns) in both treatment groups. none of these events were considered life threatening or drug related. jaundice was the only adverse event occurring more frequently with transderm scōp® than placebo: 9 events (7.9%) versus 2 events (1.8%) (p=0.031). jaundice, a common occurrence in newborns, resolved with ultraviolet light and did not prolong the hospital stay. there are no adequ

United States - English - NLM (National Library of Medicine)

rebel distributors corp - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i), scopolamine hydrobromide (unii: 451ifr0gxb) (scopolamine - unii:dl48g20x8x) - phenobarbital 16.2 mg in 5 ml - fda has classified the following indications as "possibly" effective:  for use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.  may also be useful as adjunctive therapy in the treatment of duodenal ulcer.  it has not been shown conclusively whether anticholinergic/antispasmodic drugs aid in the healing of a duodenal ulcer, decrease the rate of recurrences or prevent complications. quadrapax elixir is contraindicated in patients with known hypersensitivity to any of the ingredients.  phenobarbital is contraindicated in patients with acute intermittent porphyria and in those patients in which phenobarbital produces restlessness and/or excitement. it is also contraindicated in patients with glaucoma, obstructive uropathy; paralytic ileus; myasthenia gravis; intestinal atony; unstable cardiovascular status in acute hemorrhage; hiatal hernia associated with reflux esophagitis; obstructive disease of the gastrointestinal tr

United States - English - NLM (National Library of Medicine)

winder laboratories llc - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i), scopolamine hydrobromide (unii: 451ifr0gxb) (scopolamine - unii:dl48g20x8x) - based on the national academy of sciences-national research council's review of this drug and/or other information, fda has classified the following indications as "possibly" effective: for use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis. may also be useful as adjunctive therapy in the treatment of duodenal ulcer. it has not been shown conclusively whether anticholinergic / antispasmodic drugs aid in the healing of a duodenal ulcer, decrease the rate of recurrences, or prevent complications. phenohytro® elixir is contraindicated in patients with known hypersensitivity to any of the ingredients. phenobarbital is contraindicated in patients with acute intermittent porphyria and in those patients in which phenobarbital produces restlessness and/or excitement. phenohytro® elixir is also contraindicated in patients with glaucoma, obstructive uropathy; paralytic ileus; myasthenia gravis; intestinal atony; unstable card

United States - English - NLM (National Library of Medicine)

atlantic biologicals corp. - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i), scopolamine hydrobromide (unii: 451ifr0gxb) (scopolamine - unii:dl48g20x8x) - based on the national academy of sciences-national research council's review of this drug and/or other information, fda has classified the following indications as "possibly" effective: for use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis. may also be useful as adjunctive therapy in the treatment of duodenal ulcer. it has not been shown conclusively whether anticholinergic / antispasmodic drugs aid in the healing of a duodenal ulcer, decrease the rate of recurrences, or prevent complications. phenohytro® elixir is contraindicated in patients with known hypersensitivity to any of the ingredients. phenobarbital is contraindicated in patients with acute intermittent porphyria and in those patients in which phenobarbital produces restlessness and/or excitement. phenohytro® elixir is also contraindicated in patients with glaucoma, obstructive uropathy; paralytic ileus; myasthenia gravis; intestinal atony; unstable card

United States - English - NLM (National Library of Medicine)

oasis trading - scopolamine (unii: dl48g20x8x) (scopolamine - unii:dl48g20x8x) - relieve the vomiting, nausea, dizziness, anorexia, and other symptoms resulted from sickness of cars, ships, airplanes, trains and other means of transport ■ tear the protective layer, adhere the adhesive layer to the navel or the back of your ears ■ one/ two patch per time, accoding to your body condition ■ attach 10 minutes before the travel, the effect will last about 1-3 days

United States - English - NLM (National Library of Medicine)

maitland labs of central florida - naja naja whole (unii: d279bdr31e) (naja naja whole - unii:d279bdr31e), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), scopolamine hydrobromide (unii: 451ifr0gxb) (scopolamine - unii:dl48g20x8x), sulfurous acid (unii: j1p7893f4j) (sulfurous acid - unii:j1p7893f4j) - contains cobra venom 4x hpus analgesic, anti-inflammatory contains magnesium chloride 2x hpus cold remedy contains scopolamine hydrobromide 6x hpus fever contains sulphurous acid 7x hpus cold and flu remedy reference :the homeopathic pharmacopoeia of the united states (hpus) contains 25 doses temporarily relieves symptoms associated with colds and flu,including headache, fever, rhinitis and sore throat.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

as kalceks a.s. - hyoscine butylbromide 20 mg/ml - solution for injection - 20 mg/ml - butylhyoscine bromide 20 mg/ml - butylscopolamine

Canada - English - Health Canada

homeocan inc. - scopolamine hydrobromide - tablet - 6ch - scopolamine hydrobromide 6ch - homeopathic products